EUVIMEDEUVIMED entdecken
Crossref

Ezetimibe alleviates acetic acid-induced ulcerative colitis in rats: targeting the Akt/NF-κB/STAT3/CXCL10 signaling axis

Rasha E Mostafa iD, Rehab F Abdel-Rahman iD

Journal of Pharmacy and Pharmacology · 01.04.2023 · 75 (4) · 533-543

DOI: 10.1093/jpp/rgad013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 01.04.2023. Verfasst von Rasha E Mostafa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Colorectal Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Ulcerative colitis (UC) is a relapsing inflammatory health state posing significant worldwide problems. Ezetimibe is a cholesterol-lowering drug having anti-inflammatory and pleiotropic properties.

Methods

Twenty-four rats were classified into four groups (n = 6). Group (I) was considered negative control. Acetic acid (AA) was instilled intrarectally in groups (II–IV). Group (II) was considered UC-control. Groups (III and IV) were orally treated with Ezetimibe (5 and 10 mg/kg/day; 14 days). Key finding AA installation resulted in severe macroscopic colonic lesions associated with elevations in the relative colon weight, the wet weight/length ratio and oxidative stress markers in the colorectum tissues. UC-control rats showed significantly elevated colorectal tissue CXCL10 and STAT3 gene expression. Akt, phosphorylated Akt, phosphorylated STAT3, TNF-α, IL-6 and NF-κB were expressively upregulated in the UC-control group. AA installation also resulted in significant histopathological alterations in the colorectum tissues of UC-control rats along with increasing the colorectal tissues’ immunohistochemical iNOS expression. Collectively, these data suggest activation of the Akt/NF-κB/STAT3/CXCL10 signaling axis. Ezetimibe treatment significantly ameliorated all the aforementioned parameters.

Conclusion

This is the first study to elucidate the modulatory actions of Ezetimibe against oxidative stress and inflammation associated with AA-induced UC in rats. Ezetimibe treatment mitigates UC via downregulation of the Akt/NF-κB/STAT3/CXCL10 signaling axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeColorectal NeoplasmsRatsAnimalsNF-kappa BProto-Oncogene Proteins c-aktAcetic AcidEzetimibeColon

Stichwörter der Autor:innen

AktCXCL10EzetimibeNF-κBSTAT3Ulcerative colitis

Substanzen

NF-kappa BProto-Oncogene Proteins c-aktAcetic AcidEzetimibe

Autor:innen und Institutionen

  • Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt.

ORCID-Profile: Rasha E Mostafa, Rehab F Abdel-Rahman

Zitieren

APA

Mostafa, R. E., & Abdel-Rahman, R. F. (2023). Ezetimibe alleviates acetic acid-induced ulcerative colitis in rats: targeting the Akt/NF-κB/STAT3/CXCL10 signaling axis. Journal of Pharmacy and Pharmacology, 75(4), 533-543. https://doi.org/10.1093/jpp/rgad013

Vancouver

Mostafa RE, Abdel-Rahman RF. Ezetimibe alleviates acetic acid-induced ulcerative colitis in rats: targeting the Akt/NF-κB/STAT3/CXCL10 signaling axis. Journal of Pharmacy and Pharmacology. 2023;75(4):533-543. doi:10.1093/jpp/rgad013

BibTeX
@article{Mostafa2023,
  author = {Mostafa, Rasha E and Abdel-Rahman, Rehab F},
  title = {Ezetimibe alleviates acetic acid-induced ulcerative colitis in rats: targeting the Akt/NF-κB/STAT3/CXCL10 signaling axis},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2023},
  volume = {75},
  number = {4},
  pages = {533--543},
  doi = {10.1093/jpp/rgad013}
}
Kostenlos starten →